Pulmonary Arterial Hypertension KnowledgeBase (bioinfom_tsdb)
bioinfom_tsdb
Pulmonary Arterial Hypertension KnowledgeBase
General information | Literature | Expression | Regulation | Variant | Interaction

Basic Information

Gene ID

634

Name

CEACAM1

Synonymous

BGP|BGP1|BGPI;carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein);CEACAM1;carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)

Definition

CD66a antigen|antigen CD66|carcinoembryonic antigen-related cell adhesion molecule 1

Position

19q13.2

Gene Type

protein-coding

Gene Regulation:

Upstream microRNAs
Transcription Factors
Post Transcriptional Modification From dbPTM
Methylation Profile From DiseaseMeth database

Experimentally verified miRNA from miRTarBase   [Top]

There is no record for CEACAM1

Transcription Factors   [Top]

Regulation From TransFac database

BGPI(h) + ATP --EGFR(h)--> BGPI(h){pY} + ADP (phosphorylation)
DC-SIGN(h) + BGPI(h) <==> DC-SIGN(h):BGPI(h) (binding)
BGPI(h) + DC-SIGN(m.s.) <==> BGPI(h):DC-SIGN(m.s.) (binding)
CEACAM1(h) --> BGPI(h) (expression).
CEACAM1(h) --> BGPI-D(h) (expression).
CEACAM1(h) --> BGPI-I(h) (expression).
CEACAM1(h) --> BGPI-H(h) (expression).
CEACAM1(h) --> BGPI-G(h) (expression).
beta-catenin(m.s.) + BGPI-A(h) <==> beta-catenin(m.s.):BGPI-A(h) (binding)
beta-catenin(h) + BGPI-A(h) <==> beta-catenin(h):BGPI-A(h) (binding)
CEACAM1(h) --> BGPI-A(h) (expression).

Post Transcriptional Modification   [Top]

Location (AA)

PTM type

Literature

Database

35Pyrrolidone carboxylic acid.Swiss-Prot 53.0
104N-linked (GlcNAc...).Swiss-Prot 53.0
111N-linked (GlcNAc...).Swiss-Prot 53.0
115N-linked (GlcNAc...).Swiss-Prot 53.0
152N-linked (GlcNAc...).Swiss-Prot 53.0
182N-linked (GlcNAc...) (Potential).Swiss-Prot 53.0
197N-linked (GlcNAc...) (Potential).Swiss-Prot 53.0
208N-linked (GlcNAc...) (Potential).Swiss-Prot 53.0
224N-linked (GlcNAc...) (Potential).Swiss-Prot 53.0
232N-linked (GlcNAc...) (Potential).Swiss-Prot 53.0
254N-linked (GlcNAc...).Swiss-Prot 53.0
274N-linked (GlcNAc...) (Potential).Swiss-Prot 53.0
288N-linked (GlcNAc...) (Potential).Swiss-Prot 53.0
292N-linked (GlcNAc...) (Potential).Swiss-Prot 53.0
302N-linked (GlcNAc...) (Potential).Swiss-Prot 53.0
309N-linked (GlcNAc...) (Potential).Swiss-Prot 53.0
345N-linked (GlcNAc...) (Potential).Swiss-Prot 53.0
351N-linked (GlcNAc...) (Potential).Swiss-Prot 53.0
363N-linked (GlcNAc...) (Potential).Swiss-Prot 53.0
378N-linked (GlcNAc...) (Potential).Swiss-Prot 53.0
405N-linked (GlcNAc...) (Potential).Swiss-Prot 53.0
493Phosphotyrosine9867848Phospho.ELM 6.0
520Phosphotyrosine9867848Phospho.ELM 6.0
508Phosphoserine11850617Phospho.ELM 6.0

Methylation Profile   [Top]

Chromosome

Location

Source

chr19

Promoter: 47723979 - 47725979GoldenGate_Methylation_Cancer_Panel_I

chr19

Promoter: 47723979 - 47725979GoldenGate_Methylation_Cancer_Panel_I


')